The dissolution profile of inhaled drugs underpins therapeutic efficacy and is an area of increasing regulatory scrutiny, particularly for the demonstration of bioequivalence in a generic. The new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback